Paper · 804483

Fractions of lipopolysaccharide from Escherichia coli O111:B4 prepared by two extraction procedures.

Morrison DC and 1 other. J Biol Chem, 1975. Cited by 370 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Fractions of lipopolysaccharide from Escherichia coli O111:B4 prepared by two extraction procedures. Papers, record 804483. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/804483

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Fractions of lipopolysaccharide from Escherichia coli O111:B4 prepared by two extraction procedures.; PubMed
Journal: J Biol Chem; PubMed
Year: 1975; PubMed
Publication types: Comparative Study, Journal Article; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/804483/; PubMed
The journal: https://conductscience.org/library/journal-index/2985121R; PubMed
Citations, by iCite: 370; iCite
Relative citation ratio, by iCite: 10.7; iCite
Revised in PubMed: 2021-02-10; PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename	Kind	ORCID iD
1	Morrison DC	D C
2	Leive L	L

Source PubMed

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Escherichia coli	Major topic
Lipopolysaccharides	Major topic
Polysaccharides, Bacterial	Major topic
Butanols
Carbohydrates
Centrifugation, Density Gradient
Chromatography, Gel
Evaluation Studies as Topic
Fatty Acids
Immunodiffusion
Methods
Molecular Weight
Phenols
Sodium Dodecyl Sulfate
Ultracentrifugation

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by125

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 370 citations.

PMID	Title	Journal	Year	In Papers	Source
39,065,030	Molecular Mechanisms of Bacterial Resistance to Antimicrobial Peptides in the Modern Era: An Updated Review.	Microorganisms	2024	https://conductscience.org/library/papers/39065030	PubMed
37,632,008	Compounding Achromobacter Phages for Therapeutic Applications.	Viruses	2023	https://conductscience.org/library/papers/37632008	PubMed
35,087,922	Extraction and Electrophoretic Analysis of Bacterial Lipopolysaccharides and Outer Membrane Proteins.	Bio Protoc	2021	https://conductscience.org/library/papers/35087922	PubMed
34,081,246	Treatment with Histone Deacetylase Inhibitor Attenuates Peripheral Inflammation-Induced Cognitive Dysfunction and Microglial Activation: The Effect of SAHA as a Peripheral HDAC Inhibitor.	Neurochem Res	2021	https://conductscience.org/library/papers/34081246	PubMed
33,467,503	Ruminal Lipopolysaccharides Analysis: Uncharted Waters with Promising Signs.	Animals (Basel)	2021	https://conductscience.org/library/papers/33467503	PubMed
31,124,046	Applications of different solvents and conditions for differential extraction of lipopolysaccharide in Gram-negative bacteria.	J Microbiol	2019	https://conductscience.org/library/papers/31124046	PubMed
30,581,431	Bactericidal/Permeability-Increasing Protein Is an Enhancer of Bacterial Lipoprotein Recognition.	Front Immunol	2018	https://conductscience.org/library/papers/30581431	PubMed
29,405,825	O-specific polysaccharide confers lysozyme resistance to extraintestinal pathogenic Escherichia coli.	Virulence	2018	https://conductscience.org/library/papers/29405825	PubMed
27,670,746	Bartonella quintana lipopolysaccharide (LPS): structure and characteristics of a potent TLR4 antagonist for in-vitro and in-vivo applications.	Sci Rep	2016	https://conductscience.org/library/papers/27670746	PubMed
27,547,567	Phage on tap-a quick and efficient protocol for the preparation of bacteriophage laboratory stocks.	PeerJ	2016	https://conductscience.org/library/papers/27547567	PubMed

1 to 10 of 125

See all 125 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/804483

GET https://conductscience.org/api/papers/v1/804483/cited_by?page=2

API reference For AI assistants